N3-PEG8-Phe-Lys-PABC-Gefitinib ctivation inhibitor 1 ML-18 inhibits specific 125I-BA1 (DTyr-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2)BB6-14

ML-18 inhibits specific 125I-BA1 (DTyr-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2)BB6-14 binding to NCI-H1299 lung cancer cells stably transfected with BRS-3 with IC50 values of 4

N3-PEG8-Phe-Lys-PABC-Gefitinib ctivation inhibitor 1 ML-18 inhibits specific 125I-BA1 (DTyr-Gln-Trp-Ala-Val-βAla-His-Phe-Nle-NH2)BB6-14N3 PEG8 Phe Lys PABC Gefitinib is a drug linker conjugate for ADC with potent antitumor activity by using the anti tumor agent, Gefitinib (orally active EGFR tyrosine kinase inhibitor), linked via the cleavable linker N3 PEG8 Phe Lys PABC. Product information Molecular Weight: 1250. 80 Formula: C60H81ClFN11O15 Chemical Name: [4 [[(2S) 6 amino 2 [[(2S) 2 [3 [2 [2 [2 [2 [2 [2 [2 (2